Skip to main content

FDA Approvals

Drug Updates, FDA Approvals, Payers' Guide

Revlimid (Lenalidomide) Now FDA Approved as First-Line Therapy for Patients with Multiple Myeloma

Lisa A. Raedler, PhD, RPh

Drug Updates, FDA Approvals, Payers' Guide

Tresiba (Insulin Degludec Injection) and Ryzodeg 70/30 (Insulin Degludec and Insulin Aspart Injection): Two New Insulin Analogs for Glycemic Control in Diabetes Mellitus

Lisa A. Raedler, PhD, RPh

Drug Updates, FDA Approvals, Payers' Guide

Zarxio (Filgrastim-sndz): First Biosimilar Approved in the United States

Lisa A. Raedler, PhD, RPh

Drug Updates, FDA Approvals, Payers' Guide

Competition Heats Up in Rheumatoid Arthritis and Other Autoimmune Conditions

Gary Branning, MBA

Drug Updates, FDA Approvals, Payers' Guide

Empliciti (Elotuzumab): First SLAMF7 Antibody Therapy Approved for the Treatment of Patients with Previously Treated Multiple Myeloma

Lisa A. Raedler, PhD, RPh

FDA Approvals, In the News, Select Drug Profiles

FDA Approves Integra Omnigraft Dermal Regeneration Matrix to Treat Diabetic Foot Ulcers

Drug Updates, FDA Approvals, Select Drug Profiles

Onivyde (Irinotecan Liposome Injection) a New Treatment Option for Patients with Metastatic Pancreatic Cancer

FDA Approvals, In the News, Select Drug Profiles

FDA Approves First Seasonal Influenza Vaccine Containing an Adjuvant

FDA Approvals, In the News, Select Drug Profiles

FDA Approves Bridion to Reverse Effects of Neuromuscular Blocking Drugs Used During Surgery

FDA Approvals, In the News, Select Drug Profiles

FDA Approves First Emergency Treatment for Overdose of Certain Types of Chemotherapy

23
24
25
26
27
28
29

Page 26 of 31
Results 251 - 260 of 305